Diclofenamide Completed Phase 3 Trials for Hypokalemic Periodic Paralysis / Paralysis, Hyperkalemic Periodic / Paramyotonia Congenita Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00004802Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders
NCT00494507Hyper- and Hypokalemic Periodic Paralysis Study